Michael R Hayden is Director of IONIS PHARMACEUTICALS INC. Currently has a direct ownership of 30,219 shares of IONS, which is worth approximately $1.39 Million. The most recent transaction as insider was on Jul 17, 2023, when has been sold 7,110 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.2K
0% 3M change
30.77% 12M change
Total Value Held $1.39 Million

Michael R Hayden Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 17 2023
BUY
Exercise of conversion of derivative security
-
7,110 Added 19.05%
30,219 Common Stock
Oct 17 2022
BUY
Exercise of conversion of derivative security
-
1,777 Added 7.14%
23,109 Common Stock
Jul 15 2022
BUY
Exercise of conversion of derivative security
-
7,110 Added 25.0%
21,332 Common Stock
Oct 15 2021
BUY
Exercise of conversion of derivative security
-
1,777 Added 11.11%
14,222 Common Stock
Jul 15 2021
BUY
Exercise of conversion of derivative security
-
7,111 Added 36.36%
12,445 Common Stock
Oct 15 2020
BUY
Exercise of conversion of derivative security
-
1,778 Added 25.0%
5,334 Common Stock

Also insider at

ABCL
AbCellera Biologics Inc. Healthcare
AUPH
Aurinia Pharmaceuticals Inc. Healthcare
XENE
Xenon Pharmaceuticals Inc. Healthcare
ETNB
89bio, Inc. Healthcare
MRH

Michael R Hayden

Director
Carlsbad, CA

Track Institutional and Insider Activities on IONS

Follow IONIS PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IONS shares.

Notify only if

Insider Trading

Get notified when an Ionis Pharmaceuticals Inc insider buys or sells IONS shares.

Notify only if

News

Receive news related to IONIS PHARMACEUTICALS INC

Track Activities on IONS